Adient (NYSE:ADNT) Price Target Lowered to $16.00 at Morgan Stanley
Adient (NYSE:ADNT – Free Report) had its price objective reduced by Morgan Stanley from $17.00 to $16.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have an underweight rating on the stock. Several other brokerages also recently weighed in on ADNT. UBS Group upped their target price on shares of […]
